Fielmann AG
General ticker "FLMNF" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $4.9B (TTM average)
Fielmann AG does not follow the US Stock Market performance with the rate: -37.2%.
Estimated limits based on current volatility of 0.0%: low 50.75$, high 50.75$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-07-14, amount 1.34$ (Y2.64%)
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [50.49$, 74.14$]
- 2026-12-31 to 2027-12-31 estimated range: [52.80$, 77.41$]
Financial Metrics affecting the FLMNF estimates:
- Negative: with PPE of 21.5 at the end of fiscal year the price was high
- Positive: 6.59 < Operating cash flow per share per price, % of 10.80
- Positive: 7.54 < Operating profit margin, % of 13.29
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.16 > 6.06
- Positive: 19.24 < Shareholder equity ratio, % of 36.84 <= 42.59
- Positive: Inventory ratio change, % of -1.91 <= -0.75
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term FLMNF quotes
Long-term FLMNF plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | €2,264.12MM | €2,434.42MM |
| Operating Expenses | €1,922.44MM | €2,111.00MM |
| Operating Income | €341.68MM | €323.42MM |
| Non-Operating Income | €-122.83MM | €-31.85MM |
| Interest Expense | €41.87MM | €43.67MM |
| Income(Loss) | €218.85MM | €291.58MM |
| Taxes | €64.64MM | €86.16MM |
| Net Income(Loss)* | €152.11MM | €203.66MM |
| Stockholders Equity | €899.13MM | €981.41MM |
| Inventory | €259.32MM | €222.13MM |
| Assets | €2,368.95MM | €2,663.94MM |
| Operating Cash Flow | €410.09MM | €464.56MM |
| Capital expenditure | €82.69MM | €112.67MM |
| Investing Cash Flow | €-331.17MM | €-116.49MM |
| Financing Cash Flow | €-44.27MM | €-223.55MM |
| Earnings Per Share** | €1.81 | €2.43 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.